Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 95Head and Neck Neoplasms 92Nasopharyngeal Carcinoma 35Nasopharyngeal Neoplasms 15Laryngeal Neoplasms 12Oropharyngeal Neoplasms 10Mouth Neoplasms 10Hypopharyngeal Neoplasms 9Colorectal Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Neoplasms 7Carcinoma, Squamous Cell 7Neoplasm Metastasis 6Esophageal Neoplasms 6Carcinoma 6Stomach Neoplasms 5Tongue Neoplasms 4Recurrence 4Parkinson Disease 4, Autosomal Dominant Lewy Body 4Ovarian Neoplasms 4Laryngeal Diseases 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Sarcoma 3Salivary Gland Neoplasms 3Lung Neoplasms 3Breast Neoplasms 3Thyroid Neoplasms 2Pharyngeal Neoplasms 2

Interventions

spartalizumab 1Oxaliplatin 1Nivolumab 1Leucovorin 1Fluorouracil 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Spinocerebellar Degenerations × Fluorouracil × Head & Neck × Clear all
NCT06544655 2026-04-17

A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors

Bristol-Myers Squibb

Phase 1 Active not recruiting
213 enrolled
GastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Spinocerebellar Degenerations, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡